The clinical trials with IDs NCT04729855 and NCT04269746 emphasize the role of specific lncRNAs such as HOTTIP and CCAT1 in CRC, investigating their potential as less-invasive prognostic markers and exploring their correlation with susceptibility to chemotherapy. The gene discussed is HOTTIP; the disease is colorectal carcinoma.